Unbiased AI-powered news
2 stories related to this topic, newest first.
fda.govAn FDA advisory committee is scheduled to evaluate authorizing compounding pharmacies to produce certain injectable peptides in July 2026. This follows a March 2026 public meeting where peptide inclusion in oral dietary supplements was discussed. The moves come amid ongoing debat…
medpagetoday.comThe U.S. Food and Drug Administration announced a panel meeting to discuss permitting compounding pharmacies to manufacture seven specific peptides. The meeting is scheduled for July 23 and 24. This follows the agency's 2023 decision to remove 19 peptides from an approved list fo…